2024-11-20T12:17:51+08:002024-11-20|Publish|
  1. Zheng G, Chattopadhyay S, Sundquist J, Sundquist K, Ji J. Antihypertensive drug targets and breast cancer risk: A two-sample mendelian randomization study. European Journal of Epidemiology. 2024;39(5):535-548.
  2. Yi H, Zhang N, Huang J, Zheng Y, Hong QH, Sundquist J, Sundquist K, Zheng X, Ji J. Association of levonorgestrel-releasing intrauterine device with gynecologic and breast cancers: A national cohort study in sweden. American Journal of Obstetrics and Gynecology. 2024;231(4):450 e1-450 e12.
  3. Yi H, Ji J. Uncovering causal clues in the development of second primary cancers. Lancet Oncology. 2024;25(3):e97.
  4. Xiao J, Zhang N, Gao Z, Wei Y, Wei H, Qiu Z, Sundquist K, Sundquist J, Ji J, Huang W. Phosphodiesterase 5 and its inhibitors with ischemic heart disease: A mendelian randomization analysis and a real-world study. Eur Heart J Cardiovasc Pharmacother. 2024;
  5. Sun W, Zhang X, Li N, He Y, Ji J, Zheng D. Genetic association of glycemic traits and antihyperglycemic agent target genes with the risk of lung cancer: A mendelian randomization study. Diabetes & Metabolic Syndrome. 2024;18(6):103048.
  6. Pan H, Niu, J., Feng, L., Yin, Y., Dang, C., Lu, Y., Li, L., Ji, J., Yang, K., Wang, L., Li, Q. Covid-19 and cognitive impairment: From evidence to sars-cov-2 mechanism. Brain-X. 2024;2:e58.
  7. Liu Y, Jiang Z, Sundquist J, Sundquist K, Ji J. Long-term pattern of psychotropic medication uses among swedish parents of children diagnosed with cancer. J Natl Compr Canc Netw. 2024;22(9)
  8. Li N, Yi H, Sun W, Sundquist J, Sundquist K, Zhang X, Zheng D, Ji J. Revealing genes associated with cervical cancer in distinct immune cells: A comprehensive mendelian randomization analysis. International Journal of Cancer. 2024;155(1):149-158.
  9. Huang W, Yang X, Zhang N, Chen K, Xiao J, Qiu Z, You S, Gao Z, Ji J, Chen L. Pde5 inhibition mitigates heart failure in hyperlipidemia. Biomedicine and Pharmacotherapy. 2024;175:116710.
  10. Huang Q, Chen Y, Lian L, Lei Q, Chen J, Wu L, Hemminki K, Ji J, Chen T. Burden of malignant mesothelioma in china during 1990-2019 and the projections through 2029. J Natl Cancer Cent. 2024;4(3):214-222.
  11. Hou R, Dou J, Wu L, Zhang X, Li C, Wang W, Gao Z, Tang X, Yan L, Wan Q, et al. Development and validation of a machine learning-based model to predict isolated post-challenge hyperglycemia in middle-aged and elder adults: Analysis from a multicentric study. Diabetes/Metabolism Research and Reviews. 2024;40(5):e3832.
  12. Dong F, He K, Zhang S, Song K, Jiang L, Hu LP, Li Q, Zhang XL, Zhang N, Li BT, et al. Ssri antidepressant citalopram reverses the warburg effect to inhibit hepatocellular carcinoma by directly targeting glut1. Cell Reports. 2024;43(10):114818.
  13. Zheng D, Li N, Hou R, Zhang X, Wu L, Sundquist J, Sundquist K, Ji J. Glucagon-like peptide-1 receptor agonists and diabetic retinopathy: Nationwide cohort and mendelian randomization studies. BMC Medicine. 2023;21(1):40.
  14. Zhang N, Li Y, Sundquist J, Sundquist K, Ji J. Identifying actionable druggable targets for breast cancer: Mendelian randomization and population-based analyses. EBioMedicine. 2023;98:104859.
  15. Xiao J, Ji J, Zhang N, Yang X, Chen K, Chen L, Huang W. Association of genetically predicted lipid traits and lipid-modifying targets with heart failure. Eur J Prev Cardiol. 2023;30(4):358-366.
  16. Wang Y, Zhang Y, Zhang M, Zhang X, Li H, Wang Y, Wang W, Ji J, Wu L, Zheng D. The prevalence of adverse reactions among individuals with three-dose covid-19 vaccination. J Infect Public Health. 2023;16(1):125-132.
  17. Liu Y, Sundquist J, Sundquist K, Zheng D, Ji J. Mental health outcomes in parents of children with a cancer diagnosis in sweden: A nationwide cohort study. EClinicalMedicine. 2023;55:101734.
  18. Li N, Zhang X, Zhang M, Wu L, Li C, Pan Y, Wang W, Ji J, Zheng D. Associations of genetically determined lipid traits and lipid-modifying agents with the risk of diabetic retinopathy: A mendelian randomization study. Atherosclerosis. 2023;369:9-16.
  19. Huang S, Zhang NQ, Xu CJ, Huang WQ, Li DX, Li J, Yao LL, Sundquist K, Sundquist J, Jiang SH, et al. Dipyridamole enhances the anti-cancer ability of aspirin against colorectal cancer by inducing apoptosis in an unfolded protein response-dependent manner. Cellular Oncology (Dordrecht). 2023;46(4):953-967.
  20. Hemminki K, Ji J, Sundquist J. Re: Mark n. Brook, holly ni raghallaigh, koveela govindasami, et al. Family history of prostate cancer and survival outcomes in the uk genetic prostate cancer study. Eur urol 2023;83:257-66. European Urology. 2023;84(1):e13-e14.
  21. Zheng G, Sundquist J, Sundquist K, Ji J. Prostate cancer incidence and survival in relation to prostate cancer as second cancer in relatives. Cancer Med. 2022;11(10):2117-2124.
  22. Zheng G, Sundquist J, Sundquist K, Ji J. Colorectal cancer risk in association with colorectal cancer as a second malignancy in relatives: A nationwide cohort study. BMC Cancer. 2022;22(1):902.
  23. Zhang N, Sundquist J, Sundquist K, Ji J. Proguanil and atovaquone use is associated with lower colorectal cancer risk: A nationwide cohort study. BMC Medicine. 2022;20(1):439.
  24. Zhang N, Sundquist J, Sundquist K, Ji J. Use of selective serotonin reuptake inhibitors is associated with a lower risk of colorectal cancer among people with family history. Cancers. 2022;14(23)
  25. Wang Y, Zhang L, Han F, Li R, Cheng Y, Jiang X, Wang L, Chen J, Ji J, Zhang Y, et al. Using period analysis to timely assess and predict 5-year relative survival for liver cancer patients from taizhou, eastern china. Frontiers in Oncology. 2022;12:920094.
  26. Jiang SH, Liu D, Hu LP, Zhang S, Yu Y, Sun YW, Ji J, Zhang ZG. Modeling of cancer-related body-wide effects identifies ltb4 as a diagnostic biomarker for pancreatic cancer. EBioMedicine. 2022;80:104050.
  27. Ji J, Sundquist J, Sundquist K, Zheng G. Familial risk associated with lung cancer as a second primary malignancy in first-degree relatives. BMC Cancer. 2022;22(1):1057.
  28. Huang Y, Ji J, Zhao Q, Song J. Editorial: Regulation of endoplasmic reticulum and mitochondria in cellular homeostasis. Front Cell Dev Biol. 2022;10:1004376.
  29. Huang W, Sundquist K, Sundquist J, Ji J. Use of dipyridamole is associated with lower risk of lymphoid neoplasms: A propensity score-matched cohort study. British Journal of Haematology. 2022;196(3):690-699.
  30. Hu LP, Huang W, Wang X, Xu C, Qin WT, Li D, Tian G, Li Q, Zhou Y, Chen S, et al. Terbinafine prevents colorectal cancer growth by inducing dntp starvation and reducing immune suppression. Molecular Therapy. 2022;30(10):3284-3299.
  31. Zöller B, Svensson PJ, Huang W, Jianguang J. Reactome pathway analysis of venous thromboembolism, peripheral artery disease, stroke, and coronary artery disease. Thrombosis and Haemostasis. 2021;121(7):964-966.
  32. Zhou KX, Huang S, Hu LP, Zhang XL, Qin WT, Zhang YL, Yao LL, Yu Y, Zhou YQ, Zhu L, et al. Increased nuclear transporter kpna2 contributes to tumor immune evasion by enhancing pd-l1 expression in pdac. J Immunol Res. 2021;2021:6694392.
  33. Zheng G, Sundquist J, Sundquist K, Ji J. Association of post-diagnostic use of cholera vaccine with survival outcome in breast cancer patients. British Journal of Cancer. 2021;124(2):506-512.
  34. Zheng G, Sundquist J, Sundquist K, Ji J. Beta-blockers use and risk of breast cancer in women with hypertension. Cancer Epidemiol Biomarkers Prev. 2021;30(5):965-973.
  35. Zheng G, Sundquist J, Sundquist K, Ji J. Family history of breast cancer as a second primary malignancy in relatives: A nationwide cohort study. BMC Cancer. 2021;21(1):1210.
  36. Zhang Z, Ji J, Liu H. Drug repurposing in oncology: Current evidence and future direction. Current Medicinal Chemistry. 2021;28(11):2175-2194.
  37. Zhang N, Sundquist J, Sundquist K, Zhang ZG, Ji J. Combined use of aspirin and selective serotonin reuptake inhibitors is associated with lower risk of colorectal cancer: A nested case-control study. American Journal of Gastroenterology. 2021;116(6):1313-1321.
  38. Zhang N, Sundquist J, Sundquist K, Zhang ZG, Ji J. Correction to: Combined use of aspirin and selective serotonin reuptake inhibitors is associated with lower risk of colorectal cancer: A nested case-control study. American Journal of Gastroenterology. 2021;116(11):2310.
  39. Zhang N, Sundquist J, Sundquist K, Ji J. Use of melatonin is associated with lower risk of colorectal cancer in older adults. Clin Transl Gastroenterol. 2021;12(8):e00396.
  40. Stenman E, Palmer K, Ryden S, Savblom C, Ji J, Sundquist J. Diagnostic center for primary care patients with nonspecific symptoms and suspected cancer: Compliance to workflow and accuracy of tests and examinations. Scandinavian Journal of Primary Health Care. 2021;39(2):148-156.
  41. Nie H, Huang PQ, Jiang SH, Yang Q, Hu LP, Yang XM, Li J, Wang YH, Li Q, Zhang YF, et al. The short isoform of prlr suppresses the pentose phosphate pathway and nucleotide synthesis through the nek9-hippo axis in pancreatic cancer. Theranostics. 2021;11(8):3898-3915.
  42. Huang W, Xiao J, Ji J, Chen L. Association of lipid-lowering drugs with covid-19 outcomes from a mendelian randomization study. Elife. 2021;10
  43. Huang W, Sundquist K, Sundquist J, Ji J. Psychiatric disorders in offspring of childhood or adolescent central nervous system tumor survivors: A national cohort study. Cancer Med. 2021;10(2):675-683.
  44. Huang W, Sundquist K, Sundquist J, Ji J. Risk of somatic diseases in offspring of survivors with childhood or adolescent central nervous system tumor in sweden. International Journal of Cancer. 2021;148(9):2184-2192.
  45. Zhang N, Sundquist J, Sundquist K, Ji J. An increasing trend in the prevalence of polypharmacy in sweden: A nationwide register-based study. Frontiers in Pharmacology. 2020;11:326.
  46. Yin Y, Ji J, Zhao J, Chen S, Tian W. Clinical and epidemiological features of heart-hand syndrome, an updated analysis in china. BMC Musculoskeletal Disorders. 2020;21(1):777.
  47. Sundquist J, Palmer K, Ryden S, Savblom C, Ji J, Stenman E. Time intervals under the lens at sweden’s first diagnostic center for primary care patients with nonspecific symptoms of cancer. A comparison with matched control patients. Frontiers in Oncology. 2020;10:561379.
  48. Sun M, Wang Y, Sundquist J, Sundquist K, Ji J. Temporal trends of sex disparity in incidence and survival of colorectal cancer: Variations by anatomical site and age at diagnosis. Clinical Epidemiology. 2020;12:73-81.
  49. Sun M, Wang Y, Sundquist J, Sundquist K, Ji J. The association between cancer and dementia: A national cohort study in sweden. Frontiers in Oncology. 2020;10:73.
  50. Ma LL, Yin X, Li BH, Yang JY, Jin YH, Huang D, Deng T, Wang YY, Ren XQ, Ji J, et al. Coronavirus disease 2019 related clinical studies: A cross-sectional analysis. Frontiers in Pharmacology. 2020;11:540187.
  51. Lindgren MP, Ji J, Smith JG, Sundquist J, Sundquist K, Zoller B. Mortality risks associated with sibling heart failure. International Journal of Cardiology. 2020;307:114-118.
  52. Liao G, Jiang X, She B, Tang H, Wang Z, Zhou H, Ma Y, Xu W, Xu H, Chen W, et al. Multi-infection patterns and co-infection preference of 27 human papillomavirus types among 137,943 gynecological outpatients across china. Frontiers in Oncology. 2020;10:449.
  53. Jin YH, Zhan QY, Peng ZY, Ren XQ, Yin XT, Cai L, Yuan YF, Yue JR, Zhang XC, Yang QW, et al. Chemoprophylaxis, diagnosis, treatments, and discharge management of covid-19: An evidence-based clinical practice guideline (updated version). Mil Med Res. 2020;7(1):41.
  54. Huang W, Sundquist K, Sundquist J, Ji J. Poor academic performance in offspring of survivors with childhood or adolescent central nervous system tumor in sweden. International Journal of Cancer. 2020;147(10):2687-2694.
  55. Huang W, Sundquist K, Sundquist J, Ji J. Risk of being born preterm in offspring of cancer survivors: A national cohort study. Frontiers in Oncology. 2020;10:1352.
  56. Huang W, Sundquist K, Sundquist J, Crump C, Ji J. Risk of being born preterm in offspring of survivors with childhood or adolescent central nervous system tumor in sweden. International Journal of Cancer. 2020;147(1):100-106.
  57. Huang W, Sundquist J, Sundquist K, Ji J. Phosphodiesterase-5 inhibitors use and risk for mortality and metastases among male patients with colorectal cancer. Nat Commun. 2020;11(1):3191.
  58. Hemminki K, Huang W, Sundquist J, Sundquist K, Ji J. Autoimmune diseases and hematological malignancies: Exploring the underlying mechanisms from epidemiological evidence. Seminars in Cancer Biology. 2020;64:114-121.
  59. Chen T, Shu X, Liu H, Ji J. Editorial: Cancer epidemiology in china: What we have learnt so far? Frontiers in Oncology. 2020;10:106.
  60. Ai JW, Zi H, Wang Y, Huang Q, Wang N, Li LY, Pei B, Ji J, Zeng XT. Clinical characteristics of covid-19 patients with gastrointestinal symptoms: An analysis of seven patients in china. Front Med (Lausanne). 2020;7:308.
  61. Stenman E, Palmer K, Ryden S, Savblom C, Svensson I, Rose C, Ji J, Nilbert M, Sundquist J. Diagnostic spectrum and time intervals in sweden’s first diagnostic center for patients with nonspecific symptoms of cancer. Acta Oncologica. 2019;58(3):296-305.
  62. Ji J, Sundquist J, Sundquist K. Use of terbinafine and risk of death in patients with prostate cancer: A population-based cohort study. International Journal of Cancer. 2019;144(8):1888-1895.
  63. Ji J, Huang W, Sundquist J, Sundquist K. Hospitalization rate in offspring of cancer survivors: A national cohort study. Journal of Cancer Survivorship. 2019;13(2):187-196.
  64. Huang W, Sundquist J, Sundquist K, Ji J. Use of phosphodiesterase 5 inhibitors is associated with lower risk of colorectal cancer in men with benign colorectal neoplasms. Gastroenterology. 2019;157(3):672-681 e4.
  65. Huang W, Sundquist J, Sundquist K, Ji J. Mortality patterns in long-term survivors of childhood or adolescent central nervous system tumour in sweden. Journal of Neuro-Oncology. 2019;145(3):541-549.
  66. Yin Y, Ji J, Borné Y, Wang Y, Zhao J, Chen S, Tian W. Clinical and epidemiological features of heart-hand syndrome: A hospital-based study in china. Scientific Reports. 2018;8(1):8469.
  67. Yang XM, Cao XY, He P, Li J, Feng MX, Zhang YL, Zhang XL, Wang YH, Yang Q, Zhu L, et al. Overexpression of rac gtpase activating protein 1 contributes to proliferation of cancer cells by reducing hippo signaling to promote cytokinesis. Gastroenterology. 2018;155(4):1233-1249.e22.
  68. Ji J, Sundquist J, Sundquist K. Cholera vaccine use is associated with a reduced risk of death in patients with colorectal cancer: A population-based study. Gastroenterology. 2018;154(1):86-92 e1.
  69. Ji J, Sundquist J, Sundquist K. Use of hormone replacement therapy improves the prognosis in patients with colorectal cancer: A population-based study in sweden. International Journal of Cancer. 2018;142(10):2003-2010.
  70. Ji J, Sundquist J, Sundquist K. Family history of autoimmune diseases and risk of gastric cancer: A national cohort study. European Journal of Cancer Prevention. 2018;27(3):221-226.
  71. Ji J, Sundquist J, Sundquist K. Congenital malformation in offspring of female cancer survivors: A national cohort study. European Journal of Cancer Prevention. 2018;27(3):274-278.
  72. Ji J, Sundquist J, Sundquist K. Increased incidence of inguinal hernia in offspring of female survivors of childhood central nervous system tumors. International Journal of Cancer. 2018;143(3):591-596.
  73. Ji J, Sundquist J, Sundquist K. Association between post-diagnostic use of cholera vaccine and risk of death in prostate cancer patients. Nat Commun. 2018;9(1):2367.
  74. Ji J, Chen T, Sundquist J, Sundquist K. Type 1 diabetes in parents and risk of attention deficit/hyperactivity disorder in offspring: A population-based study in sweden. Diabetes Care. 2018;41(4):770-774.
  75. Zoller B, Ji J, Sundquist J, Sundquist K. Body height and incident risk of venous thromboembolism: A cosibling design. Circulation: Cardiovascular Genetics. 2017;10(5)
  76. Nikberg M, Ji J, Leppert J, Sundquist K, Chabok A. Socioeconomic characteristics and comorbidities of diverticular disease in sweden 1997-2012. International Journal of Colorectal Disease. 2017;32(11):1591-1596.
  77. Long EC, Lonn SL, Ji J, Lichtenstein P, Sundquist J, Sundquist K, Kendler KS. Resilience and risk for alcohol use disorders: A swedish twin study. Alcoholism, Clinical and Experimental Research. 2017;41(1):149-155.
  78. Liu X, Chen Y, Wang Y, Dong X, Wang J, Tang J, Sundquist K, Sundquist J, Ji J. Cancer risk in patients with hepatitis c virus infection: A population-based study in sweden. Cancer Med. 2017;6(5):1135-1140.
  79. Karriker-Jaffe KJ, Ji J, Sundquist J, Kendler KS, Sundquist K. Disparities in pharmacotherapy for alcohol use disorder in the context of universal health care: A swedish register study. Addiction. 2017;112(8):1386-1394.
  80. Ji J, Sundquist J, Sundquist K. Associations of alcohol use disorders with esophageal and gastric cancers: A population-based study in sweden. European Journal of Cancer Prevention. 2017;26(2):119-124.
  81. Ji J, Dimitrijevic I, Sundquist J, Sundquist K, Zoller B. Risk of ocular manifestations in patients with giant cell arteritis: A nationwide study in sweden. Scandinavian Journal of Rheumatology. 2017;46(6):484-489.
  82. Zoller B, Li X, Ohlsson H, Ji J, Memon AA, Svensson PJ, Palmer K, Dahlback B, Sundquist J, Sundquist K. Epidemiology of familial aggregation of venous thromboembolism. Seminars in Thrombosis and Hemostasis. 2016;42(8):821-832.
  83. Zoller B, Ji J, Sundquist J, Sundquist K. High risk of venous thromboembolism in klinefelter syndrome. J Am Heart Assoc. 2016;5(5)
  84. Patel CJ, Ji J, Sundquist J, Ioannidis JP, Sundquist K. Systematic assessment of pharmaceutical prescriptions in association with cancer risk: A method to conduct a population-wide medication-wide longitudinal study. Scientific Reports. 2016;6:31308.
  85. Ji J, Zoller B, Sundquist J, Sundquist K. Risk of solid tumors and hematological malignancy in persons with turner and klinefelter syndromes: A national cohort study. International Journal of Cancer. 2016;139(4):754-8.
  86. Ji J, Sundquist J, Sundquist K. Association of alcohol use disorders with amyotrophic lateral sclerosis: A swedish national cohort study. European Journal of Neurology. 2016;23(2):270-5.
  87. Ji J, Sundquist J, Sundquist K. Association of tamoxifen with meningioma: A population-based study in sweden. European Journal of Cancer Prevention. 2016;25(1):29-33.
  88. Ji J, Sundquist J, Sundquist K. Association between anorexia nervosa and type 2 diabetes in sweden: Etiological clue for the primary prevention of type 2 diabetes. Endocrine Research. 2016;41(4):310-316.
  89. Ji J, Sundquist J, Sundquist K. Gender-specific incidence of autoimmune diseases from national registers. Journal of Autoimmunity. 2016;69:102-6.
  90. Ji J, Sundquist J, Sundquist K. Stillbirth and neonatal death among female cancer survivors: A national cohort study. International Journal of Cancer. 2016;139(5):1046-52.
  91. Ji J, Sundquist J, Sundquist K. Incidence and familial risk of pleural mesothelioma in sweden: A national cohort study. European Respiratory Journal. 2016;48(3):873-9.
  92. Ji J, Sundquist J, Sundquist K. Tonsillectomy associated with an increased risk of autoimmune diseases: A national cohort study. Journal of Autoimmunity. 2016;72:1-7.
  93. Ji J, Sundquist J, Sundquist K. Risk of ischemic stroke varies by ethnicity in patients with atrial fibrillation: A swedish national cohort study. European Journal of Internal Medicine. 2016;36:e13-e15.
  94. Ji J, Sundquist J, Sundquist K. Association of family history of type 2 diabetes with prostate cancer: A national cohort study. Frontiers in Oncology. 2016;6:194.
  95. Hemminki K, Sundquist K, Sundquist J, Hemminki A, Ji J. Location of metastases in cancer of unknown primary are not random and signal familial clustering. Scientific Reports. 2016;6:22891.
  96. Hemminki K, Pavlidis N, Tsilidis KK, Sundquist K, Ji J. Age-dependent metastatic spread and survival: Cancer of unknown primary as a model. Scientific Reports. 2016;6:23725.
  97. Hemminki K, Liu X, Ji J, Forsti A. Origin of b-cell neoplasms in autoimmune disease. PloS One. 2016;11(6):e0158360.
  98. Freccero C, Sundquist K, Sundquist J, Ji J. Primary adherence to antidepressant prescriptions in primary health care: A population-based study in sweden. Scandinavian Journal of Primary Health Care. 2016;34(1):83-8.
  99. Zoller B, Li X, Ohlsson H, Ji J, Sundquist J, Sundquist K. Family history of venous thromboembolism as a risk factor and genetic research tool. Thrombosis and Haemostasis. 2015;114(5):890-900.
  100. Zoller B, Ji J, Sundquist J, Sundquist K. Alcohol use disorders are associated with venous thromboembolism. J Thromb Thrombolysis. 2015;40(2):167-73.
  101. Sundquist K, Sundquist J, Ji J. Contribution of shared environmental factors to familial aggregation of common cancers: An adoption study in sweden. European Journal of Cancer Prevention. 2015;24(2):162-4.
  102. Liu X, Hemminki K, Forsti A, Sundquist K, Sundquist J, Ji J. Cancer risk in patients with type 2 diabetes mellitus and their relatives. International Journal of Cancer. 2015;137(4):903-10.
  103. Liu X, Hemminki K, Forsti A, Sundquist J, Sundquist K, Ji J. Cancer risk and mortality in asthma patients: A swedish national cohort study. Acta Oncologica. 2015;54(8):1120-7.
  104. Kendler KS, Ji J, Edwards AC, Ohlsson H, Sundquist J, Sundquist K. An extended swedish national adoption study of alcohol use disorder. JAMA Psychiatry. 2015;72(3):211-8.
  105. Ji J, Zoller B, Giaccia A, Haile R, Sundquist J, Sundquist K. Risk of breast cancer among patients with bioprosthetic or mechanical valve replacement: A population-based study in sweden. Breast Cancer Research and Treatment. 2015;154(2):369-75.
  106. Ji J, Sundquist J, Sundquist K. Lactose intolerance and risk of lung, breast and ovarian cancers: Aetiological clues from a population-based study in sweden. British Journal of Cancer. 2015;112(1):149-52.
  107. Hemminki K, Sundquist K, Sundquist J, Ji J. Risk of cancer of unknown primary after hospitalization for autoimmune diseases. International Journal of Cancer. 2015;137(12):2885-95.
  108. Hemminki K, Liu X, Forsti A, Sundquist J, Sundquist K, Ji J. Subsequent type 2 diabetes in patients with autoimmune disease. Scientific Reports. 2015;5:13871.
  109. Zoller B, Ji J, Sundquist J, Sundquist K. Venous thromboembolism and varicose veins share familial susceptibility: A nationwide family study in sweden. J Am Heart Assoc. 2014;3(4)
  110. Sundquist K, Sundquist J, Ji J. Risk of hepatocellular carcinoma and cancers at other sites among patients diagnosed with chronic hepatitis b virus infection in sweden. Journal of Medical Virology. 2014;86(1):18-22.
  111. Sundquist J, Sundquist K, Ji J. Autism and attention-deficit/hyperactivity disorder among individuals with a family history of alcohol use disorders. Elife. 2014;3:e02917.
  112. Sun Y, Zhang W, Chen D, Lv Y, Zheng J, Lilljebjörn H, Ran L, Bao Z, Soneson C, Sjögren HO, et al. A glioma classification scheme based on coexpression modules of egfr and pdgfra. Proceedings of the National Academy of Sciences of the United States of America. 2014;111(9):3538-43.
  113. Ji J, Sundquist J, Sundquist K. Alcohol consumption has a protective effect against hematological malignancies: A population-based study in sweden including 420,489 individuals with alcohol use disorders. Neoplasia. 2014;16(3):229-34, 234 e1.
  114. Hemminki K, Forsti A, Fallah M, Sundquist J, Sundquist K, Ji J. Risk of cancer in patients with medically diagnosed hay fever or allergic rhinitis. International Journal of Cancer. 2014;135(10):2397-403.
  115. Frank C, Fallah M, Ji J, Sundquist J, Hemminki K. The population impact of familial cancer, a major cause of cancer. International Journal of Cancer. 2014;134(8):1899-906.
  116. Fallah M, Liu X, Ji J, Forsti A, Sundquist K, Hemminki K. Hodgkin lymphoma after autoimmune diseases by age at diagnosis and histological subtype. Annals of Oncology. 2014;25(7):1397-1404.
  117. Fallah M, Liu X, Ji J, Forsti A, Sundquist K, Hemminki K. Autoimmune diseases associated with non-hodgkin lymphoma: A nationwide cohort study. Annals of Oncology. 2014;25(10):2025-2030.
  118. Chen T, Hemminki K, Kharazmi E, Ji J, Sundquist K, Fallah M. Multiple primary (even in situ) melanomas in a patient pose significant risk to family members. European Journal of Cancer. 2014;50(15):2659-67.
  119. Chen T, Fallah M, Kharazmi E, Ji J, Sundquist K, Hemminki K. Effect of a detailed family history of melanoma on risk for other tumors: A cohort study based on the nationwide swedish family-cancer database. Journal of Investigative Dermatology. 2014;134(4):930-936.
  120. Castro FA, Liu X, Forsti A, Ji J, Sundquist J, Sundquist K, Koshiol J, Hemminki K. Increased risk of hepatobiliary cancers after hospitalization for autoimmune disease. Clinical Gastroenterology and Hepatology. 2014;12(6):1038-45 e7.
  121. Zoller B, Ji J, Sundquist J, Sundquist K. Shared and nonshared familial susceptibility to surgically treated inguinal hernia, femoral hernia, incisional hernia, epigastric hernia, and umbilical hernia. Journal of the American College of Surgeons. 2013;217(2):289-99 e1.
  122. Liu X, Ji J, Forsti A, Sundquist K, Sundquist J, Hemminki K. Autoimmune disease and subsequent urological cancer. Journal of Urology. 2013;189(6):2262-8.
  123. Ji J, Sundquist K, Ning Y, Kendler KS, Sundquist J, Chen X. Incidence of cancer in patients with schizophrenia and their first-degree relatives: A population-based study in sweden. Schizophrenia Bulletin. 2013;39(3):527-36.
  124. Hemminki K, Liu X, Forsti A, Ji J, Sundquist J, Sundquist K. Subsequent leukaemia in autoimmune disease patients. British Journal of Haematology. 2013;161(5):677-687.
  125. Hemminki K, Liu X, Forsti A, Ji J, Sundquist J, Sundquist K. Subsequent brain tumors in patients with autoimmune disease. Neuro-Oncology. 2013;15(9):1142-50.
  126. Calling S, Ji J, Sundquist J, Sundquist K, Zoller B. Shared and non-shared familial susceptibility of coronary heart disease, ischemic stroke, peripheral artery disease and aortic disease. International Journal of Cardiology. 2013;168(3):2844-50.
  127. Zoller B, Ji J, Sundquist J, Sundquist K. Risk of coronary heart disease in patients with cancer: A nationwide follow-up study from sweden. European Journal of Cancer. 2012;48(1):121-8.
  128. Zoller B, Ji J, Sundquist J, Sundquist K. Risk of haemorrhagic and ischaemic stroke in patients with cancer: A nationwide follow-up study from sweden. European Journal of Cancer. 2012;48(12):1875-83.
  129. Zoller B, Ji J, Sundquist J, Sundquist K. Family history and risk of hospital treatment for varicose veins in sweden. British Journal of Surgery. 2012;99(7):948-53.
  130. Shu X, Liu H, Ji J, Sundquist K, Forsti A, Sundquist J, Hemminki K. Subsequent cancers in patients diagnosed with cancer of unknown primary (cup): Etiological insights? Annals of Oncology. 2012;23(1):269-275.
  131. Liu X, Ji J, Sundquist K, Sundquist J, Hemminki K. The impact of type 2 diabetes mellitus on cancer-specific survival: A follow-up study in sweden. Cancer. 2012;118(5):1353-61.
  132. Liu X, Ji J, Sundquist K, Sundquist J, Hemminki K. Mortality causes in cancer patients with type 2 diabetes mellitus. European Journal of Cancer Prevention. 2012;21(3):300-6.
  133. Ji J, Zoller B, Sundquist K, Sundquist J. Increased risks of coronary heart disease and stroke among spousal caregivers of cancer patients. Circulation. 2012;125(14):1742-7.
  134. Ji J, Sundquist K, Sundquist J, Hemminki K. Comparability of cancer identification among death registry, cancer registry and hospital discharge registry. International Journal of Cancer. 2012;131(9):2085-93.
  135. Ji J, Sundquist K, Sundquist J. Cancer risk after hospitalization for osteoporosis in sweden. European Journal of Cancer Prevention. 2012;21(4):395-9.
  136. Ji J, Sundquist K, Sundquist J. A population-based study of hepatitis d virus as potential risk factor for hepatocellular carcinoma. Journal of the National Cancer Institute. 2012;104(10):790-2.
  137. Ji J, Sundquist K, Sundquist J. Cancer incidence in patients with polyglutamine diseases: A population-based study in sweden. Lancet Oncology. 2012;13(6):642-8.
  138. Hemminki K, Sundquist J, Ji J. Is family history associated with improved survival in patients with gastric cancer? Journal of Clinical Oncology. 2012;30(25):3150-1; author reply 3152-3.
  139. Hemminki K, Liu X, Ji J, Sundquist J, Sundquist K. Autoimmune disease and subsequent digestive tract cancer by histology. Annals of Oncology. 2012;23(4):927-33.
  140. Hemminki K, Liu X, Ji J, Sundquist J, Sundquist K. Kaposi sarcoma and merkel cell carcinoma after autoimmune disease. International Journal of Cancer. 2012;131(3):E326-8.
  141. Hemminki K, Liu X, Ji J, Sundquist J, Sundquist K. Effect of autoimmune diseases on mortality and survival in subsequent digestive tract cancers. Annals of Oncology. 2012;23(8):2179-2184.
  142. Hemminki K, Liu X, Ji J, Sundquist J, Sundquist K. Effect of autoimmune diseases on risk and survival in histology-specific lung cancer. European Respiratory Journal. 2012;40(6):1489-95.
  143. Hemminki K, Liu X, Ji J, Forsti A, Sundquist J, Sundquist K. Effect of autoimmune diseases on risk and survival in female cancers. Gynecologic Oncology. 2012;127(1):180-5.
  144. Hemminki K, Liu X, Forsti A, Ji J, Sundquist J, Sundquist K. Effect of autoimmune diseases on incidence and survival in subsequent multiple myeloma. Journal of Hematology & Oncology. 2012;5:59.
  145. Zoller B, Ji J, Sundquist J, Sundquist K. Familial risk factors shared by venous thromboembolism and cancer: A nationwide epidemiological study of swedish families. Thrombosis Research. 2011;128(2):141-8.
  146. Sundquist K, Winkleby M, Li X, Ji J, Hemminki K, Sundquist J. Familial [corrected] transmission of coronary heart disease: A cohort study of 80,214 swedish adoptees linked to their biological and adoptive parents. American Heart Journal. 2011;162(2):317-23.
  147. Shu X, Ji J, Sundquist K, Sundquist J, Hemminki K. Survival in cancer patients with previous hospitalization for sarcoidosis: A swedish population-based cohort study during 1964-2006. Annals of Oncology. 2011;22(6):1427-1434.
  148. Shu X, Ji J, Sundquist J, Sundquist K, Hemminki K. Survival in cancer patients hospitalized for inflammatory bowel disease in sweden. Inflammatory Bowel Diseases. 2011;17(3):816-22.
  149. Shu X, Ji J, Sundquist J, Sundquist K, Hemminki K. Survival in cancer patients hospitalized for psoriasis: A population-based cohort study in sweden. British Journal of Dermatology. 2011;165(1):129-36.
  150. Sadr-Azodi O, Sundquist J, Ji J, Lundell L, Sundquist K. Risk of acute myocardial infarction and stroke after discharge from in-hospital care due to complicated and uncomplicated peptic ulcer disease. European Journal of Gastroenterology and Hepatology. 2011;23(6):461-6.
  151. Ji J FA, Hemminki K, Sundquist J, Lenner P. Survival in common cancers defined by risk and survival of family members. Oncology Reviews. 2011;5(1):13–20.
  152. Ji J, Ludvigsson JF, Sundquist K, Sundquist J, Hemminki K. Incidence of celiac disease among second-generation immigrants and adoptees from abroad in sweden: Evidence for ethnic differences in susceptibility. Scandinavian Journal of Gastroenterology. 2011;46(7-8):844-8.
  153. Ji J, Liu X, Sundquist K, Sundquist J. Survival of cancer in patients with rheumatoid arthritis: A follow-up study in sweden of patients hospitalized with rheumatoid arthritis 1 year before diagnosis of cancer. Rheumatology (Oxford, England). 2011;50(8):1513-8.
  154. Hemminki K, Liu X, Ji J, Sundquist K, Sundquist J. Subsequent copd and lung cancer in patients with autoimmune disease. European Respiratory Journal. 2011;37(2):463-5.
  155. Hemminki K, Ji J, Sundquist K, Sundquist J, Liu X. Screening detected prostate cancers in type 2 diabetics. International Journal of Cancer. 2011;129(9):2305-7.
  156. Hemminki K, Ji J, Sundquist J, Shu X. Familial risks in cancer of unknown primary: Tracking the primary sites. Journal of Clinical Oncology. 2011;29(4):435-40.
  157. Hemminki K, Bermejo JL, Ji J, Kumar R. Familial bladder cancer and the related genes. Curr Opin Urol. 2011;21(5):386-92.
  158. Shu X, Ji J, Li X, Sundquist J, Sundquist K, Hemminki K. Cancer risk in patients hospitalised for graves’ disease: A population-based cohort study in sweden. British Journal of Cancer. 2010;102(9):1397-9.
  159. Shu X, Ji J, Li X, Sundquist J, Sundquist K, Hemminki K. Cancer risk among patients hospitalized for type 1 diabetes mellitus: A population-based cohort study in sweden. Diabetic Medicine. 2010;27(7):791-7.
  160. Mousavi SM, Brandt A, Weires M, Ji J, Sundquist J, Hemminki K. Cancer incidence among iranian immigrants in sweden and iranian residents compared to the native swedish population. European Journal of Cancer. 2010;46(3):599-605.
  161. Ji J, Liu X, Sundquist K, Sundquist J, Hemminki K. Cancer risk in patients hospitalized with polymyalgia rheumatica and giant cell arteritis: A follow-up study in sweden. Rheumatology (Oxford, England). 2010;49(6):1158-63.
  162. Ji J, Hemminki K, Sundquist K, Sundquist J. Seasonal and regional variations of asthma and association with osteoporosis: Possible role of vitamin d in asthma. Journal of Asthma. 2010;47(9):1045-8.
  163. Ji J, Hemminki K, Sundquist J, Sundquist K. Ethnic differences in incidence of type 1 diabetes among second-generation immigrants and adoptees from abroad. J Clin Endocrinol Metab. 2010;95(2):847-50.
  164. Hemminki K, Mousavi SM, Brandt A, Ji J, Sundquist J. Liver and gallbladder cancer in immigrants to sweden. European Journal of Cancer. 2010;46(5):926-31.
  165. Hemminki K, Mousavi SM, Brandt A, Ji J, Sundquist J. Histology-specific risks in testicular cancer in immigrants to sweden. Endocrine-Related Cancer. 2010;17(2):329-34.
  166. Hemminki K, Ji J, Brandt A, Mousavi SM, Sundquist J. The swedish family-cancer database 2009: Prospects for histology-specific and immigrant studies. International Journal of Cancer. 2010;126(10):2259-67.
  167. Ji J, Shu X, Sundquist K, Sundquist J, Hemminki K. Cancer risk in hospitalised psoriasis patients: A follow-up study in sweden. British Journal of Cancer. 2009;100(9):1499-502.
  168. Ji J, Shu X, Li X, Sundquist K, Sundquist J, Hemminki K. Cancer risk in hospitalised asthma patients. British Journal of Cancer. 2009;100(5):829-33.
  169. Ji J, Shu X, Li X, Sundquist K, Sundquist J, Hemminki K. Cancer risk in hospitalized sarcoidosis patients: A follow-up study in sweden. Annals of Oncology. 2009;20(6):1121-6.
  170. Ji J, Forsti A, Sundquist J, Lenner P, Hemminki K. Survival in non-hodgkin’s lymphoma by histology and family history. J Cancer Res Clin Oncol. 2009;135(12):1711-6.
  171. Hemminki K, Shu X, Li X, Ji J, Sundquist K, Sundquist J. Familial risks for hospitalized graves’ disease and goiter. Eur J Endocrinol. 2009;161(4):623-9.
  172. Ji J, Forsti A, Sundquist J, Lenner P, Hemminki K. Survival in bladder and renal cell cancers is familial. Journal of the American Society of Nephrology. 2008;19(5):985-91.
  173. Ji J, Forsti A, Sundquist J, Lenner P, Hemminki K. Survival in familial pancreatic cancer. Pancreatology. 2008;8(3):252-6.
  174. Ji J, Forsti A, Sundquist J, Lenner P, Hemminki K. Survival in ovarian cancer patients by histology and family history. Acta Oncologica. 2008;47(6):1133-9.
  175. Ji J, Eng C, Hemminki K. Familial risk for soft tissue tumors: A nation-wide epidemiological study from sweden. J Cancer Res Clin Oncol. 2008;134(5):617-24.
  176. Hemminki K, Shu X, Li X, Ji J, Sundquist J, Sundquist K. Familial risks for hospitalization with endocrine diseases. J Clin Endocrinol Metab. 2008;93(12):4755-8.
  177. Hemminki K, Ji J, Forsti A, Sundquist J, Lenner P. Survival in breast cancer is familial. Breast Cancer Research and Treatment. 2008;110(1):177-82.
  178. Hemminki K, Ji J, Forsti A, Sundquist J, Lenner P. Concordance of survival in family members with prostate cancer. Journal of Clinical Oncology. 2008;26(10):1705-9.
  179. Hemminki K, Forsti A, Sundquist J, Ji J. Risk of familial breast cancer is not increased after pregnancy. Breast Cancer Research and Treatment. 2008;108(3):417-20.
  180. Ji J, Hemminki K. Risk for contralateral breast cancers in a population covered by mammography: Effects of family history, age at diagnosis and histology. Breast Cancer Research and Treatment. 2007;105(2):229-36.
  181. Ji J, Hemminki K. Familial blood vessel tumors and subsequent cancers. Annals of Oncology. 2007;18(7):1260-7.
  182. Ji J, Forsti A, Sundquist J, Hemminki K. Risks of breast, endometrial, and ovarian cancers after twin births. Endocrine-Related Cancer. 2007;14(3):703-11.
  183. Hemminki K, Sundquist J, Ji J. Familial risk for gastric carcinoma: An updated study from sweden. British Journal of Cancer. 2007;96(8):1272-7.
  184. Hemminki K, Ji J, Forsti A. Risks for familial and contralateral breast cancer interact multiplicatively and cause a high risk. Cancer Research. 2007;67(3):868-70.
  185. Hemminki K, Forsti A, Ji J. Incidence and familial risks in pituitary adenoma and associated tumors. Endocrine-Related Cancer. 2007;14(1):103-9.
  186. Ji J, Hemminki K. Socioeconomic/occupational risk factors for lymphoproliferative diseases in sweden. Annals of Epidemiology. 2006;16(5):370-6.
  187. Ji J, Hemminki K. Socioeconomic and occupational risk factors for pancreatic cancer: A cohort study in sweden. J Occup Environ Med. 2006;48(3):283-8.
  188. Ji J, Hemminki K. Second primary malignancies among patients with soft tissue tumors in sweden. International Journal of Cancer. 2006;119(4):909-14.
  189. Ji J, Hemminki K. Familial risk for esophageal cancer: An updated epidemiologic study from sweden. Clinical Gastroenterology and Hepatology. 2006;4(7):840-5.
  190. Ji J, Hemminki K. Second gastric cancers among patients with primary sporadic and familial cancers in sweden. Gut. 2006;55(6):896-8.
  191. Ji J, Hemminki K. Incidence of multiple primary malignancies among patients with bone cancers in sweden. J Cancer Res Clin Oncol. 2006;132(8):529-35.
  192. Ji J, Hemminki K. Familial risk for histology-specific bone cancers: An updated study in sweden. European Journal of Cancer. 2006;42(14):2343-9.
  193. Ji J, Hemminki K. Socio-economic and occupational risk factors for gastric cancer: A cohort study in sweden. European Journal of Cancer Prevention. 2006;15(5):391-7.
  194. Ji J, Hemminki K. Variation in the risk for liver and gallbladder cancers in socioeconomic and occupational groups in sweden with etiological implications. Int Arch Occup Environ Health. 2005;78(8):641-9.
  195. Ji J, Hemminki K. Occupation and upper aerodigestive tract cancers: A follow-up study in sweden. J Occup Environ Med. 2005;47(8):785-95.
  196. Ji J, Hemminki K. Occurrences of leukemia subtypes by socioeconomic and occupational groups in sweden. J Occup Environ Med. 2005;47(11):1131-40.
  197. Ji J, Granstrom C, Hemminki K. Occupation and bladder cancer: A cohort study in sweden. British Journal of Cancer. 2005;92(7):1276-8.
  198. Ji J, Granstrom C, Hemminki K. Occupational risk factors for kidney cancer: A cohort study in sweden. World Journal of Urology. 2005;23(4):271-8.
  199. Ji J, Couto E, Hemminki K. Incidence differences for gallbladder cancer between occupational groups suggest an etiological role for alcohol. International Journal of Cancer. 2005;116(3):492-3.